Wealth Enhancement Advisory Services
AVXL icon

Wealth Enhancement Advisory Services’s Anavex Life Sciences AVXL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.8K Buy
31,132
+1,597
+5% +$4.72K ﹤0.01% 3849
2026
Q1 		$88.3K Buy
29,535
+14,982
+103% +$64.9K ﹤0.01% 3340
2025
Q4 		$58.4K Buy
14,553
+3,068
+27% +$18.8K ﹤0.01% 3523
2025
Q3 		$112K Sell
11,485
-5,820
-34% -$59K ﹤0.01% 3313
2025
Q2 		$187K Sell
17,305
-5,323
-24% -$45.4K ﹤0.01% 3016
2025
Q1 		$194K Sell
22,628
-4,045
-15% -$38.2K ﹤0.01% 2638
2024
Q4 		$286K Buy
26,673
+10,925
+69% +$84K ﹤0.01% 2421
2024
Q3 		$89.4K Buy
15,748
+1,246
+9% +$7.19K ﹤0.01% 2577
2024
Q2 		$61.2K Buy
14,502
+422
+3% +$1.71K ﹤0.01% 2444
2024
Q1 		$71.7K Buy
14,080
+1,289
+10% +$7.26K ﹤0.01% 2323
2023
Q4 		$119K Buy
12,791
+1,916
+18% +$13.2K ﹤0.01% 2155
2023
Q3 		$71.2K Buy
+10,875
New +$86.6K ﹤0.01% 2134

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wealth Enhancement Advisory Services's AVXL Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Anavex Life Sciences (AVXL) stake by 5.4% in Q2 2026, buying an estimated $4.72K and bringing the position to 31,132 shares worth $77.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3849.

Wealth Enhancement Advisory Services first reported a position in AVXL in Q3 2023 and has held it in 12 quarters since. The position peaked at $286K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Wealth Enhancement Advisory Services held 31,132 shares of Anavex Life Sciences worth $77.8K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 1,597 Anavex Life Sciences shares in Q2 2026, an estimated $4.72K.
  • Anavex Life Sciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3849 holding.
  • Wealth Enhancement Advisory Services first reported a position in Anavex Life Sciences in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Anavex Life Sciences position peaked at $286K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.